Literature DB >> 6717923

The effect of cataract surgery on the blood--aqueous barrier.

T J Liesegang, W M Bourne, R F Brubaker.   

Abstract

Orally-administered fluorescein was used as a quantitative test of the blood-aqueous barrier in a group of patients who had undergone cataract extraction and intraocular lens implantation in one eye. There was no statistically significant difference in the concentration of fluorescein in the anterior chamber between the aphakic or pseudophakic eye and the control eye of the total group of 46 patients. Eyes with an intracapsular cataract extraction with medallion suture implant lens, however, had a significantly lower concentration of fluorescein in the anterior chamber as compared to the control eye. This difference is probably due to loss of fluorescein into the vitreous by mixing and diffusion. In eyes with an intact posterior capsule, the time course of anterior chamber fluorescence in the aphakic eye is more comparable to that of the phakic eye. In such eyes the blood-aqueous barrier seems to remain normal long after cataract extraction and intraocular lens implantation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6717923     DOI: 10.1016/s0161-6420(84)34276-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Vitreous fluorophotometric recordings in HIV infection.

Authors:  M Cellini; A Baldi
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

2.  Inflammatory response after phacoemulsification treated with 0.5% prednisolone acetate or vehicle.

Authors:  Katrin Lorenz; Burkhard Dick; Andreas Jehkul; Gerd U Auffahrt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-26       Impact factor: 3.117

3.  Recovery of the blood-aqueous barrier after cataract surgery.

Authors:  V M Ferguson; D J Spalton
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

Review 4.  Vitreous fluorophotometry: a review.

Authors:  M F Raines
Journal:  J R Soc Med       Date:  1988-07       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.